Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONStandard

NALLPEN IN PLASTIC CONTAINER

NAFCILLIN SODIUM

Standard Dose
EQ 2GM BASE/100ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview NALLPEN IN PLASTIC CONTAINER is listed in Drugs@FDA under application 050655 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient NAFCILLIN SODIUM Form and strength INJECTABLE;INJECTION - EQ 2GM BASE/100ML Sponsor BAXTER HLTHCARE Submission history Latest submission status date: 2018-04-05 00:00:00.

Structured Monograph

Clinical summary

Approval overview NALLPEN IN PLASTIC CONTAINER is listed in Drugs@FDA under application 050655 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient NAFCILLIN SODIUM Form and strength INJECTABLE;INJECTION - EQ 2GM BASE/100ML Sponsor BAXTER HLTHCARE Submission history Latest submission status date: 2018-04-05 00:00:00. Submission type: SUPPL.

Monitoring

  • Marketing status: Prescription
  • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.